Pharmacodynamic monitoring of immunosuppressive drugs.
Yatscoff
R W
RW
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Langman
L J
LJ
LeGatt
D F
DF
D000328:Adult; D001379:Azathioprine / Q000494:pharmacology* / Q000627:therapeutic use; D019703:Calcineurin; D002148:Calmodulin-Binding Proteins / Q000037:antagonists & inhibitors; D016572:Cyclosporine / Q000494:pharmacology* / Q000627:therapeutic use; D016207:Cytokines / Q000096:biosynthesis; D016903:Drug Monitoring / Q000379:methods; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D008780:Methyltransferases / Q000378:metabolism; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014181:Transplantation Immunology
D002148:Calmodulin-Binding Proteins; D016207:Cytokines; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D007168:IMP Dehydrogenase; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D019703:Calcineurin; D010749:Phosphoprotein Phosphatases; D009173:Mycophenolic Acid; D001379:Azathioprine